Evaluation of bacterial inactivation in prestorage pooled, leukoreduced, whole blood-derived platelet concentrates suspended in plasma prepared with photochemical treatment

Transfusion

Volumn 47, Issue 10, 2007, Pages 1896-1901

  Brecher, Mark E ^a   Hay, Shauna ^a   Corash, Laurence ^a   Hsu, Jocelyn ^a   Lin, Lily ^a  

^a 1021 East Wing ^*

Author keywords

[No Author keywords available]

Indexed keywords

THROMBOCYTE CONCENTRATE;

ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD SMEAR; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; INOCULATION; KLEBSIELLA PNEUMONIAE; LEUKOCYTE; MICROBIAL CONTAMINATION; NONHUMAN; PHOTOCHEMISTRY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; ULTRAVIOLET IRRADIATION;

ABO BLOOD-GROUP SYSTEM; BLOOD; BLOOD PLATELETS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LEUKOCYTES; PHOTOCHEMISTRY;

EID: 34548770668     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01413.x     Document Type: Article

References (22)

1. Silva MA, Gregory KR, Carr-Greer MA, Holmberg JA, Kuehnert MJ, Brecher ME Task Force. Summary of the AABB Interorganizational Task Force on Bacterial Contamination of Platelets: Fall 2004 impact survey. Transfusion 2006 46 : 636 41.
2. Sweeney J, Kouttab N, Holme S, Kurtis J, Cheves T, Nelson E. Storage of platelet-rich plasma-derived platelet concentrate pools in plasma and additive solution. Transfusion 2006 46 : 835 40.
3. SM platelet: whole blood derived platelets, pooled [monograph on the Internet]. East Hills (NY) : Pall Corp. c2007. Available from: http://www.pall.com/39378_39833.asp
4. Goodnough LT, Brecher ME, Kanter MH, AuBuchon JP. Medical progress: transfusion medicine. Part I. Blood transfusion. N Engl J Med 1999 340 : 438 47.
5. Shulman IA. College of American Pathologists Accreditation checklist item TRM. 44955. Phase I requirement on bacterial detection in platelets. Arch Pathol Lab Med 2004 128 : 958 63.
6. Fridey J, editor. Standards for blood banks and transfusion services. 22nd ed. Bethesda : American Association of Blood Banks 2003.
7. Whitaker BI, Sullivan M. The 2005 Nationwide Blood Collection and Utilization Survey Report [monograph on the Internet]. Rockville (MD) : US Department of Health and Human Services 2006. Available from: http://www.hhs.gov/bloodsafety/2005NBCUS.pdf
8. Nelson EJ. 510k pre-market notification. Pepper Pike (OH) : Medsep Corp. 2005. p. 1 5.
9. Nussbaumer W, Allersdorfer D, Grabmer C, Kilga S, Rheinschmidt M, Corash L, Lin L, Schoenitzer D, Lass-Floerl C. Comparison of BacTAlert and INTERCEPT in preventing the release of platelet units containing low numbers of viable bacteria. Transfusion 2005 45 : 52A 3A.
10. Centers for Disease Control and Prevention (CDC). Fatal bacterial infections associated with platelet transfusions - United States, 2004. MMWR Morb Mortal Wkly Rep 2005 25 : 168 70.
11. Fang CT, Chambers LA, Kennedy J, Strupp A, Fucci MC, Janas JA, Tang Y, Hapip CA, Lawrence TB, Dodd RY American Red Cross Regional Blood Centers. Detection of bacterial contamination in apheresis platelet products: American Red Cross experience, 2004. Transfusion 2005 45 : 1845 52.
12. Lin L, Cook DN, Wiesehahn GP, Alfonso R, Behrman B, Cimino GD, Corten L, Damonte PB, Dikeman R, Dupuis K, Fang YM, Hanson CV, Hearst JE, Lin CY, Londe HF, Metchette K, Nerio AT, Pu JT, Reames AA, Rheinschmidt M, Tessman J, Isaacs ST, Wollowitz S, Corash L. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion 1997 37 : 423 35.
13. Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion 2004 44 : 877 85.
14. Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates. Transfusion 2005 45 : 911 9.
15. AuBuchon JP, Herschel L, Roger J, Taylor H, Whitley P, Li J, Edrich R, Goodrich RP. Efficacy of apheresis platelets treated with riboflavin and ultraviolet light for pathogen reduction. Transfusion 2005 45 : 1335 41.
16. Mohr H, Redecker-Klein A. Inactivation of pathogens in platelet concentrates by using a two-step procedure. Vox Sang 2003 84 : 96 104.
17. Lin L, Dikeman R, Molini B, Lukehart SA, Lane R, Dupuis K, Metzel P, Corash L. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria. Transfusion 2004 44 : 1496 504.
18. Knutson F, Alfonso R, Dupuis K, Mayaudon V, Lin L, Corash L, Hogman CF. Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function. Vox Sang 2000 78 : 209 16.
19. Osselaer JC, Doyen C, Messe N, Van Hooydonk M, Jacquet M, Sonnet A, Bosly A, Flament J, Corash L. Routine use of platelet components prepared with photochemical treatment (INTERCEPT platelets): impact on clinical outcomes and resources. Blood 2005 106 : 129a.
20. Keuren JF, Cauwenberghs S, Heeremans J, de Kort W, Heemskerk JW, Curvers J. Platelet ADP response deteriorates in synthetic storage media. Transfusion 2006 46 : 204 12.
21. Kerkhoffs JL, Eikenboom JC, Schipperus MS, van Wordragen-Vlaswinkel RJ, Brand R, Harvey MS, de Vries RR, Barge R, van Rhenen DJ, Brand A. A muticenter randomized study of the efficacy of transfusions with platelets stored in platelet additive solution II versus plasma. Blood 2006 108 : 3210 5.
22. Singh Y, Sawyer LS, Pinkoski LS, Dupuis KW, Hsu JC, Lin L, Corash L. Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function. Transfusion 2006 46 : 1168 77.